OTCMKTS:MTACU MedTech Acquisition (MTACU) Stock Price, News & Analysis $11.35 +1.85 (+19.47%) As of 08/10/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About MedTech Acquisition Stock (OTCMKTS:MTACU) Get MedTech Acquisition alerts:Sign Up Key Stats Today's Range$10.00▼$11.3550-Day Range$11.35▼$11.3552-Week Range$9.23▼$11.43Volume1,900 shsAverage Volume585 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MedTech Acquisition Corporation is a special purpose acquisition company formed in 2021 under the laws of Delaware and listed on the OTC Markets. The company’s primary objective is to complete a business combination with one or more businesses in the medical technology or life sciences sectors. By structuring as a blank check company, MedTech Acquisition seeks to leverage public market capital and strategic support to accelerate growth in a highly innovative industry. MedTech Acquisition targets companies operating in areas such as diagnostic imaging, minimally invasive devices, regenerative medicine and digital health. Its management team comprises professionals with extensive experience in medical device development, regulatory affairs and healthcare investing. This expertise guides the identification of businesses with differentiated technologies, strong intellectual property positions and clear pathways to commercialization. Through its transaction model, MedTech Acquisition offers private medtech firms a streamlined route to public equity markets, while providing public investors with exposure to emerging healthcare technologies. The company evaluates potential targets across North America and considers opportunities in Europe and Asia, focusing on businesses with scalable operations, robust clinical data and unmet clinical needs. Upon completion of a business combination, MedTech Acquisition intends to draw on its industry relationships—including partnerships with medical centers, research institutions and corporate investors—to support post-closing growth initiatives, operational enhancements and strategic product development.AI Generated. May Contain Errors. Read More Receive MTACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MTACU Stock News HeadlinesMedtech firm NAMSA to lay off more than 50 in St. Paul after acquisitionApril 8, 2025 | msn.comHTEC Group Inc.: HTEC Acquires CertiCon Signaling Further EU Expansion and Extending MedTech, Industrial and Automotive CapabilitiesMarch 5, 2025 | finanznachrichten.deThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.June 1 at 1:00 AM | American Alternative (Ad)Boston Scientific To Acquire Medical Technology Company Cortex; Terms Not KnownNovember 4, 2024 | markets.businessinsider.comventureLAB and Sterling Industries Sign MOU to Strengthen MedTech Innovation in VaughanSeptember 27, 2024 | tmcnet.comDiamond Hill Mid Cap Fund Q2 2024 Market CommentaryAugust 22, 2024 | seekingalpha.comDiamond Hill Select Fund Q2 2024 Market CommentaryAugust 22, 2024 | seekingalpha.comFDA recalls incorrectly dispatched J&J’s Abiomed heart pumpsAugust 15, 2024 | finance.yahoo.comSee More Headlines MTACU Stock Analysis - Frequently Asked Questions How have MTACU shares performed this year? MedTech Acquisition's stock was trading at $11.35 on January 1st, 2026. Since then, MTACU shares have increased by 0.0% and is now trading at $11.35. How do I buy shares of MedTech Acquisition? Shares of MTACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryMedical Equipment Current SymbolOTCMKTS:MTACU CIK1826667 WebN/A Phone908-391-1288FaxN/AEmployees106Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:MTACU) was last updated on 6/1/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedTech Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MedTech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.